BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23789610)

  • 1. Complete clinical remission of tumor-stage granulomatous mycosis fungoides after treatment with PUVA, skin electron irradiation, oral etretinate and systemic interferon-γ.
    Yamada Y; Oka M; Fujiwara S; Nishioka E; Okamoto Y; Hayashibe K; Nishigori C
    Int J Dermatol; 2013 Jul; 52(7):893-5. PubMed ID: 23789610
    [No Abstract]   [Full Text] [Related]  

  • 2. CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid.
    Fujimura T; Aiba S; Yoshino Y; Kuroki S; Kimura Y; Kikuchi K; Kunii T; Matsunaga J; Matsushima K; Tagami H
    Dermatology; 2004; 208(3):221-6. PubMed ID: 15118371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides.
    Torii H; Kaneko T; Matsuyama T; Nakanishi H; Harada S
    J Dermatol; 1994 Oct; 21(10):767-70. PubMed ID: 7798436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycosis fungoides: a therapeutical review.
    Zinzani PL; Mazza P; Gherlinzoni F; Zanchini R; Bocchia M; Tura S
    Haematologica; 1991; 76(2):150-61. PubMed ID: 1718827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
    Molin L; Thomsen K; Volden G; Aronsson A; Hammar H; Hellbe L; Wantzin GL; Roupe G
    Acta Derm Venereol; 1987; 67(3):232-6. PubMed ID: 2442936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of PUVA-induced keratoses to etretinate.
    Hudson-Peacock MJ; Angus B; Farr PM
    J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
    Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
    Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas].
    Thiele B; Rasokat H; Mahrle G
    Z Hautkr; 1985 Jan; 60(1-2):116-9. PubMed ID: 3872538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary cutaneous lymphoma--mycosis fungoides].
    Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
    Rupoli S; Barulli S; Guiducci B; Offidani M; Mozzicafreddo G; Simonacci M; Filosa G; Giacchetti A; Ricotti G; Brandozzi G; Cataldi I; Serresi S; Ceschini R; Bugatti L; Offidani A; Giangiacomi M; Brancorsini D; Leoni P
    Haematologica; 1999 Sep; 84(9):809-13. PubMed ID: 10477454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Hammar H; Molin L; Volden G
    Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of symptomatic mucinosis follicularis in mycosis fungoides using fast electrons].
    Hagedorn M; Slanina J; Kuphal K; Wenning J
    Hautarzt; 1986 Dec; 37(12):667-72. PubMed ID: 3546197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
    Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
    Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series.
    Nikolaou V; Siakantaris MP; Vassilakopoulos TP; Papadavid E; Stratigos A; Economidi A; Marinos L; Papadaki T; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):354-7. PubMed ID: 20586838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.